
欧洲临床试验成像市场预测至 2028 年 - COVID-19 影响和区域分析 - 按模态 [断层扫描、磁共振成像 (MRI)、超声波、正电子发射断层扫描 (PET)、X 射线、超声心动图等],提供 (操作成像服务、成像软件、读取分析服务、试验设计和咨询服务等)和最终用户 [合同研究组织 (CRO)、制药和生物技术公司、学术和研究机构等]
No. of Pages: 130 | Report Code: BMIRE00028612 | Category: Life Sciences
No. of Pages: 130 | Report Code: BMIRE00028612 | Category: Life Sciences
药物开发的最终目标是带来具有经过验证的治疗效果的新化合物去市场。获得有关已进行的试验结果的准确信息对估计临床试验的成功率提出了重大挑战,因为收集此类数据昂贵、耗时且容易出错。在临床试验中对人体进行体内成像可能会提高药物开发过程的成功率。例如,正电子发射断层扫描 (PET) 成像可以可视化用于靶向药物体内活性的放射性标记化合物,或在临床试验测试期间监测化合物组织暴露。其他体内成像技术,例如磁共振成像 (MRI),可以有效地可视化人体解剖结构,并能够可视化临床试验参与者体内的药物分子,从而能够检测到足够的灵敏度和特异性。质谱成像 (MSI) 目前用于可视化离体组织切片的药物分子。因此,越来越多地使用成像技术或方式进行临床试验测试以确定临床剂量功效和毒性,从而提高临床试验的成功率,从而有利于欧洲临床试验成像市场的增长。
欧洲临床试验成像市场分为英国、德国、法国、意大利、西班牙和欧洲其他国家。新药开发的临床试验活动数量的增加和服务提供商公司推出的创新产品是可能支持预测期内欧洲市场增长的几个因素。此外,癌症、心血管疾病、神经系统疾病和传染病是德国临床试验中最常研究的疾病。临床研究受益于德国完善的交通、通讯、能源和公共服务基础设施,以及庞大的患者群体和对优质医疗保健的高需求。临床试验协调中心的成立是联邦教育和研究部旨在加强学术临床研究的新资助计划的一部分。因此,德国的临床试验审批流程标准化、可靠、透明,并且批准的研究启动时间相对较短。此外,在德国,顶级 CRO 提供用于成像研究的临床试验成像软件。 Pharmtrace 是一家位于柏林的 CRO 的“ERICA”,它为临床试验图像管理提供了一个灵活的平台,结合了临床试验医学图像的收集、集中和质量控制的法规遵从性。 ERICA 由 pharmtrace 开发和验证,旨在用于现实临床试验,以正确记录临床成像并使其符合 GCP 标准。
欧洲临床试验成像市场细分
欧洲临床试验成像市场根据模式、产品、最终用户和国家/地区进行细分。
根据模式,欧洲临床试验成像市场分为断层扫描、磁共振成像 (MRI)、超声波、正电子发射断层扫描 (PET)、X 射线、超声心动图等。断层扫描细分市场在 2023 年占据最大市场份额。
根据产品类型,欧洲临床试验成像市场分为操作成像服务、成像软件、读取分析服务、试验设计和咨询服务等。运营成像服务领域在 2023 年占据最大的市场份额。
根据最终用户,欧洲临床试验成像市场分为合同研究组织 (CRO)、制药和生物技术公司、学术和研究机构等。合同研究组织 (CRO) 细分市场在 2023 年占据最大的市场份额。
根据国家/地区,市场分为英国、德国、法国、意大利、西班牙和欧洲其他国家。德国在 2023 年占据了市场份额。
Calyx Inc、eResearch Technology Inc、ICON PLC、IXICO plc、Medical Metrics Inc、VIDA Diagnostics Inc 和 WCG Clinical Inc 是在欧洲临床试验成像市场运营的领先公司。
Strategic insights for Europe Clinical Trial Imaging involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 501.22 Million |
Market Size by 2028 | US$ 705.65 Million |
Global CAGR (2023 - 2028) | 7.1% |
Historical Data | 2021-2022 |
Forecast period | 2024-2028 |
Segments Covered |
By 模式
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Clinical Trial Imaging refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Clinical Trial Imaging Market is valued at US$ 501.22 Million in 2023, it is projected to reach US$ 705.65 Million by 2028.
As per our report Europe Clinical Trial Imaging Market, the market size is valued at US$ 501.22 Million in 2023, projecting it to reach US$ 705.65 Million by 2028. This translates to a CAGR of approximately 7.1% during the forecast period.
The Europe Clinical Trial Imaging Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Clinical Trial Imaging Market report:
The Europe Clinical Trial Imaging Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Clinical Trial Imaging Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Clinical Trial Imaging Market value chain can benefit from the information contained in a comprehensive market report.